When North Country Healthcare formed in 2016 through the merger of four rural New Hampshire hospitals, it was viewed as a ...

The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...

Lung cancer tumor cells in mice communicate with the brain, sending signals to deactivate the body’s immune response, a study ...

This publication aims to improve treatment and care for adults with chronic obstructive pulmonary disease (COPD). It provides commissioners with strategies and recommendations for frontline care, ...

Award-winning presentation recognizes AI-CVD-HF heart failure prediction model leveraging coronary artery calcium (CAC) scans ...

AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving ...

Encompass Health (NYSE:EHC) reported what executives described as a “very strong” fourth quarter, capping a “stellar” 2025 ...

Clinical and health care resource use burden were greater among patients with diagnosed hypereosinophilic syndrome or predicted hypereosinophilic syndrome via machine learning vs. those without the ...

The implantable blood pressure sensor will now be available to patients with chronic heart failure through the NHS.

The combination of GENEROUS for Medicaid, Globe for Medicare Part B and Guard for Medicare Part D will heavily impact the US drug market. President Trump’s rhetoric has been that other countries ...

GlobalData forecasts 7% CAGR growth for India’s diagnostic imaging market through 2035, supported by infrastructure upgrades and demand for affordable respiratory diagnostics.

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.